The analgesic effect of total intravenous anaesthesia with propofol versus inhalational anaesthesia for acute postoperative pain after hepatectomy: a randomized controlled trial

• Published in: BMC anesthesiology Vol. 23; no. 1; p. 112
• Main Authors: Wong, Stanley S C, Wang, Fengfeng, Chan, Timmy C W, Cheung, C W
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 03-04-2023; BioMed Central; BMC
• Subjects: Adolescent; Adult; Adverse effects; Aged; Aged, 80 and over; Analgesics; Analgesics - therapeutic use; Anesthesia; Anesthesia, Intravenous - methods; Anesthetics, Inhalation; Anesthetics, Intravenous; Blood pressure; Care and treatment; Clinical trials; Constipation; Drug dosages; General anesthesia; Hepatectomy; Hepatectomy - adverse effects; Humans; Liver; Medical societies; Middle Aged; Morphine; Morphine consumption; Morphine Derivatives - therapeutic use; Narcotics; Pain; Pain scores; Pain, Postoperative; Pain, Postoperative - chemically induced; Pain, Postoperative - drug therapy; Pain, Postoperative - prevention & control; Patient satisfaction; Patients; Phenols; Postoperative period; Propofol; Propofol TIVA; Prospective Studies; Sevoflurane; Surgery; Young Adult; Hong Kong China; China; Morphine consumption; Pain scores; Adverse effects; Propofol TIVA; Hepatectomy
• ISSN: 1471-2253; 1471-2253
• DOI: 10.1186/s12871-023-02063-7

Postoperative pain control can be challenging in patients undergoing hepatectomy. A previous retrospective study on hepatobiliary/ pancreatic surgeries showed better postoperative pain control in patients who received propofol TIVA. The aim of this study was to determine the analgesic effect of propofol TIVA for hepatectomy. This clinical study has been registered at ClinicalTrials.gov (NCT03597997).
A prospective randomized controlled trial was performed to compare the analgesic effect of propofol TIVA versus inhalational anaesthesia. Patients aged between 18 and 80 years old with an American Society of Anesthesiologist (ASA) physical status of I-III scheduled for elective hepatectomy were recruited. Ninety patients were randomly allocated to receive either propofol TIVA (TIVA group) or inhalational anaesthesia with sevoflurane (SEVO group). Perioperative anaesthetic/analgesic management was the same for both groups. Numerical rating scale (NRS) pain scores, postoperative morphine consumption, quality of recovery, patient satisfaction and adverse effects were evaluated during the acute postoperative period and at 3 and 6 months after surgery.
No significant differences were found for acute postoperative pain scores (both at rest and during coughing) and postoperative morphine consumption between TIVA and SEVO groups. Patients given TIVA had lower pain scores with coughing at 3 months after surgery (p = 0.014, and FDR < 0.1). TIVA group was associated with better quality of recovery on postoperative day (POD) 3 (p = 0.038, and FDR < 0.1), less nausea (p = 0.011, and FDR < 0.1 on POD 2; p = 0.013, and FDR < 0.1 on POD 3) and constipation (p = 0.013, and FDR < 0.1 on POD 3).
Propofol TIVA did not improve acute postoperative pain control compared to inhalational anaesthesia in patients who underwent hepatectomy. Our results do not support the use of propofol TIVA for reducing acute postoperative pain after hepatectomy.